Cargando…

Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?

The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikaki, Alexandra, Alexopoulos, Athanasios, Vlachou, Fani, Filippi, Vasiliki, Andreou, Ioannis, Rapti, Vasiliki, Gogos, Konstantinos, Dalianis, Konstantinos, Efthymiadou, Roxani, Prassopoulos, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096626/
https://www.ncbi.nlm.nih.gov/pubmed/27277326
http://dx.doi.org/10.4274/mirt.22932
_version_ 1782465497468502016
author Nikaki, Alexandra
Alexopoulos, Athanasios
Vlachou, Fani
Filippi, Vasiliki
Andreou, Ioannis
Rapti, Vasiliki
Gogos, Konstantinos
Dalianis, Konstantinos
Efthymiadou, Roxani
Prassopoulos, Vassilios
author_facet Nikaki, Alexandra
Alexopoulos, Athanasios
Vlachou, Fani
Filippi, Vasiliki
Andreou, Ioannis
Rapti, Vasiliki
Gogos, Konstantinos
Dalianis, Konstantinos
Efthymiadou, Roxani
Prassopoulos, Vassilios
author_sort Nikaki, Alexandra
collection PubMed
description The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease.
format Online
Article
Text
id pubmed-5096626
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Galenos Publishing
record_format MEDLINE/PubMed
spelling pubmed-50966262016-11-14 Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation? Nikaki, Alexandra Alexopoulos, Athanasios Vlachou, Fani Filippi, Vasiliki Andreou, Ioannis Rapti, Vasiliki Gogos, Konstantinos Dalianis, Konstantinos Efthymiadou, Roxani Prassopoulos, Vassilios Mol Imaging Radionucl Ther Case Report The contribution of positron emission tomography/computed tomography (PET/CT) with 18F-fludeoxyglucose (FDG) in evaluating ovarian cancer recurrence even after a prolonged disease-free interval, and in therapy response is well-described. Calcifications observed in CT, although usually attributed to benign conditions, may actually represent active disease. Such an example of calcified formations is psammoma bodies. We present a case of 56-y. o. patient with ovarian cancer relapse at the supraclavicular area 18 years after complete response and disease-free interval. The patient received chemotherapy and underwent 18F-FDG-PET/CT for the evaluation of treatment response. Both CT corrected and uncorrected PET images showed hypermetabolism in the massively calcified lymph nodes in the neck, mediastinum, axilla and abdomen, indicative of active residual disease. Galenos Publishing 2016-06 2016-06-06 /pmc/articles/PMC5096626/ /pubmed/27277326 http://dx.doi.org/10.4274/mirt.22932 Text en © Molecular Imaging and Radionuclide Therapy, Published by Galenos Publishing. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Nikaki, Alexandra
Alexopoulos, Athanasios
Vlachou, Fani
Filippi, Vasiliki
Andreou, Ioannis
Rapti, Vasiliki
Gogos, Konstantinos
Dalianis, Konstantinos
Efthymiadou, Roxani
Prassopoulos, Vassilios
Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title_full Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title_fullStr Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title_full_unstemmed Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title_short Hypermetabolic Calcified Lymph Nodes on 18Fludeoxyglucose-Positron Emission Tomography/Computed Tomography in a Case of Treated Ovarian Cancer Recurrence: Residual Disease or Benign Formation?
title_sort hypermetabolic calcified lymph nodes on 18fludeoxyglucose-positron emission tomography/computed tomography in a case of treated ovarian cancer recurrence: residual disease or benign formation?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5096626/
https://www.ncbi.nlm.nih.gov/pubmed/27277326
http://dx.doi.org/10.4274/mirt.22932
work_keys_str_mv AT nikakialexandra hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT alexopoulosathanasios hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT vlachoufani hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT filippivasiliki hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT andreouioannis hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT raptivasiliki hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT gogoskonstantinos hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT dalianiskonstantinos hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT efthymiadouroxani hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation
AT prassopoulosvassilios hypermetaboliccalcifiedlymphnodeson18fludeoxyglucosepositronemissiontomographycomputedtomographyinacaseoftreatedovariancancerrecurrenceresidualdiseaseorbenignformation